First do no harm: Surrogate endpoints and the lesson of β-agonists in acute lung injury

Critical Care

Volumn 16, Issue 3, 2012, Pages

  Lakshminarayana, Pradeep H ^a   Kahn, Jeremy M ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SALBUTAMOL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ACUTE LUNG INJURY; AEROSOL; ARTIFICIAL VENTILATION; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART RATE; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; LUNG EDEMA; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOTE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INTUBATION; SIDE EFFECT; THORAX RADIOGRAPHY; TREATMENT OUTCOME; FEMALE; MALE;

ACUTE LUNG INJURY; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ALBUTEROL; FEMALE; HUMANS; MALE;

EID: 84862764038     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11392     Document Type: Note

References (8)

1. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353:1685-1693. 10.1056/NEJMoa050333, 16236739.
2. Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002, 82:569-600.
3. Sakuma T, Okaniwa G, Nakada T, et al. Alveolar fluid clearance in the resected human lung. Am J Respir Crit Care Med 1994, 150:305-310.
4. Perkins GD, McAuley DF, Thickett DR, et al. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006, 173:281-287. 10.1164/rccm.200508-1302OC, 16254268.
5. , Matthay MA, Brower RG, et al. National Heart, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011, 184:561-568. National Heart, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network.
6. Gao SF, Perkins GD, Gates S, et al. Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomized controlled trial. Lancet 2012, 379:229-235. 10.1016/S0140-6736(11)61623-1, 3266479, 22166903.
7. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled?. Ann Intern Med 1996, 125:605-613.
8. Rubenfeld GD. Surrogate measures of patient-centered outcomes in critical care. Update in Intensive Care and Emergency Medicine 2003,